Samyang Foods Inc. (KRX: 003230) reported a 22.9% operating margin for the June quarter. Instant noodles. Nestlé runs in the high teens on a good year, Nissin in the single digits to low teens. A company selling ₩770.3 billion of packaged food in three months and keeping ₩176.2 billion of it at the operating line is doing something structurally different from the industry it appears to belong to.
Part of what it's doing is genuinely rare, and part of it is a currency. Separating the two is the whole exercise here, because the market is paying 23.9 times trailing earnings and 7.53 times book on the assumption that the 22.9% is the new normal.
Overseas revenue in the quarter was ₩645.8 billion, up 46.7% from a year earlier and past ₩600 billion for the first time. That's 83.8% of everything Samyang sold. Domestic Korea accounted for roughly ₩124 billion, which is less than the US subsidiary alone.
The geographic split, on the company's reported subsidiary figures, runs to about ₩203.6 billion from the US entity, up 54.3%, ₩181.0 billion from China, up 44.1%, ₩80.6 billion from Europe, up 61%, and smaller contributions from the UK, Japan and Indonesia. Add those and you get roughly ₩519 billion, leaving about ₩127 billion sold into markets where Samyang has no local company at all. Vietnam is the example people point to. That gap is worth noticing because it's the cheapest revenue on the page, sold to distributors out of a Korean plant with no local overhead attached.
The concentration in one product is extreme and it's the reason the numbers look like this. Samyang accounts for around 66% of all instant ramen exported from Korea, which is another way of saying Buldak did something no marketing budget has managed to reproduce. Growth of 39.3% in revenue against a year earlier, at this scale, in a category that grows at low single digits globally, is not category growth. It's share taken from everyone.
Here's the quarter underneath the headline. Gross margin was 48.1%, against 42.4% in the March quarter and 46.2% a year ago. That's a 5.7 point jump in three months, which for a food manufacturer is enormous and doesn't come from operating improvement at that speed.
None of it reached operating income. SG&A was ₩194.4 billion in the June quarter against ₩125.8 billion in March, rising from 17.6% of revenue to 25.2%. Operating income came in at ₩176.2 billion against ₩177.1 billion the prior quarter, essentially flat, on revenue that grew 7.8%.
Two readings. The charitable one is that Samyang is deliberately spending a favourable gross margin on shelf space, distribution and advertising in the US and Europe while the brand has momentum, which is what you want a company in this position to do. The less charitable one is that selling in developed retail costs what it costs, and the 2026 first-quarter SG&A ratio of 17.6% was the anomaly rather than the trend. The full-year 2025 ratio was 22.5%, which sits between them and is probably the better guide.
The won weakened to ₩1,561.5 per dollar on June 6, its lowest against the dollar since March 2009. That was inside the quarter Samyang just reported. By late August the currency had rallied to around ₩1,372, its strongest since July 2025, helped by Bank of Korea rate hikes and heavy exporter dollar selling.
Run the arithmetic on what that does. Samyang manufactures in Korea, at Miryang and Wonju, and sells 83.8% of its output abroad. Won costs, foreign revenue. The naive sensitivity is brutal: if translated overseas revenue fell 10% purely on currency while the Korean cost base didn't move, that's roughly ₩65 billion off the top line and most of it off an operating income of ₩176.2 billion.
The real number is smaller, for reasons worth stating rather than glossing. Only part of the overseas book is dollar-linked. China's ₩181.0 billion is renminbi, Europe's ₩80.6 billion is euro, and the local subsidiaries carry local costs that move with local revenue. Wheat and palm oil, the two biggest raw material inputs, are priced in dollars, so a stronger won cuts input costs at the same time it cuts translated revenue. That's a partial natural hedge and it's the reason gross margin, not revenue, is the line to watch.
But partial is the operative word. The company has not disclosed a currency sensitivity in a form that lets an outsider size it precisely, and the direction is not ambiguous. The June quarter caught the most favourable won in seventeen years. The September quarter will not.
At ₩1,547,000 a share and 7.53 million shares outstanding, the market capitalization is ₩11.65 trillion. Trailing twelve-month net income of about ₩488 billion puts the shares at 23.9 times earnings, and equity of ₩1,548.3 billion puts them at 7.53 times book.
Twenty-four times is not an aggressive multiple for a company compounding revenue at nearly 40%. The 2021 operating margin was 10.2%, 2023 was 12.4%, 2024 was 19.9%, and 2025 was 22.3%. Multiple expansion has followed margin expansion, which is the normal order of things. What it means is that the multiple contains no cushion for margin reversion. A return to a 19% or 20% operating margin, which is still an exceptional number for this industry, takes about ₩25 billion a quarter out of operating income before any revenue growth is considered.
Cash generation deserves a mention too. Operating cash flow in the June quarter was ₩56.9 billion against ₩176.2 billion of operating income. Inventories rose ₩43.9 billion and trade receivables rose ₩43.0 billion over the three months. Export growth of this speed absorbs working capital, and the gap between reported profit and cash is the visible cost of it. Half-year operating cash flow was ₩268.3 billion against ₩353.3 billion of operating income, so this isn't yet a problem. It's a thing to track.
The bear argument here has been available for three years and has been wrong for three years, which is worth saying out loud. The claim that Buldak is a social-media fad has been rebutted every quarter since 2023, most recently by 54.3% growth in the US and 61% in Europe from a base that is no longer small. Fads don't do that in their fourth year.
Capacity, which was the real constraint, has been addressed. Capital expenditure was ₩449.0 billion in 2025, with ₩273.3 billion in a single quarter, and property, plant and equipment has grown from ₩665.0 billion in September 2024 to ₩1,157.7 billion. First-half 2026 capex was only ₩103.3 billion, which says the heavy build is behind them and the operating leverage from it is ahead.
Balance sheet risk is minimal. Cash and equivalents stood at ₩630.6 billion at the end of June against total liabilities of ₩1,200.4 billion, with equity of ₩1,548.3 billion. The board declared an interim cash dividend of ₩3,200 a share on August 12, totalling ₩24.1 billion, a yield of 0.3%. That's a company that has decided returning capital isn't the priority yet, and given where the growth is, it's hard to argue.
The third quarter report in November is the clean read, because it's the first full quarter in which the won averaged well above its June low. Watch gross margin against the 48.1% just posted. If it holds near there with the won 10%-plus stronger, the pricing power is real and the currency was a smaller contributor than the timing suggests. If it slides toward the low forties, the June quarter was partly a translation effect and the 23.9 times multiple is being applied to a peak.
The second line is SG&A as a share of revenue. Anything near the 25.2% just recorded, sustained, means the cost of holding US and European shelf space is structurally higher than the 2025 average of 22.5%, and that the operating margin settles below where it is now regardless of what the currency does.
kstock reads DART every morning and writes up what moved — the contract, the buyback, the number that does not add up. The daily post and a Saturday roundup, by email.